Circulating Progenitor Cells and Childhood Cardiovascular Disease

Eric J Kort1,2,3, Lacey Croskey4, Taryn Scibienski4

  • 1DeVos Cardiovascular Research Program of Spectrum Health and Van Andel Research Institute, 100 Michigan Street NE, Grand Rapids, MI, 49503, USA. eric.kort@vai.org.

Pediatric Cardiology
|November 12, 2015
PubMed

Insights

Research on circulating progenitor cells in adult heart disease is extensive. However, studies in children with cardiovascular disease are limited, highlighting a need for further investigation into their role and therapeutic potential.

Area of Science:

  • Cardiovascular Research
  • Cellular Biology
  • Pediatric Medicine

Background:

  • Circulating progenitor cells are well-studied in adult myocardial injury and recovery.
  • These cells show potential as therapeutic agents in adult cardiovascular disease.
  • Knowledge regarding progenitor cells in pediatric cardiovascular disease remains limited.

Purpose of the Study:

  • To review current knowledge on circulating progenitor cells in childhood cardiovascular disease.
  • To identify research gaps and future directions in this field.

Main Methods:

  • Literature review of existing studies on circulating progenitor cells in pediatric cardiovascular disease.

Main Results:

  • Limited studies currently exist on circulating progenitor cells in children.
  • The role and therapeutic potential of these cells in pediatric cardiovascular conditions are not well-defined.

Conclusions:

  • Further research is urgently needed to understand circulating progenitor cells in childhood cardiovascular disease.
  • Establishing the significance of these cells could lead to novel diagnostic and therapeutic strategies for pediatric heart conditions.

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
5.6K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.8K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.4K